Guilherme Fregonezi1, Ingrid G Azevedo2, Vanessa R Resqueti2, Armèle D De Andrade3, Lucien P Gualdi2, Andrea Aliverti4, Mário Et Dourado-Junior5, Verônica F Parreira6. 1. Physical Therapy Department of Universidade Federal do Rio Grande do Norte, Natal, Brazil fregonezi@ufrnet.br. 2. Physical Therapy Department of Universidade Federal do Rio Grande do Norte, Natal, Brazil. 3. Physical Therapy Department of Universidade Federal de Pernambuco, Recife, Brazil. 4. Dipartimento di Elettronica, Informazione e Bioingegneria-Politecnico di Milano, Milan, Italy. 5. Hospital Universitário Onofre Lopes-Universidade Federal do Rio Grande do Norte, Natal, Brazil. 6. Physical Therapy Department of Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Abstract
BACKGROUND: Neuromuscular diseases (NMDs) lead to different weakness patterns, and most patients with NMDs develop respiratory failure. Inspiratory and expiratory muscle strength can be measured by maximum static inspiratory pressure (PImax) and maximum static expiratory pressure (PEmax), and the relationship between them has not been well described in healthy subjects and subjects with NMDs. Our aim was to assess expiratory/inspiratory muscle strength in NMDs and healthy subjects and calculate PEmax/PImax ratio for these groups. METHODS: Seventy (35 males) subjects with NMDs (amyotrophic lateral sclerosis, myasthenia gravis, and myotonic dystrophy), and 93 (47 males) healthy individuals 20-80 y of age were evaluated for anthropometry, pulmonary function, PImax, and PEmax, respectively. RESULTS: Healthy individuals showed greater values for PImax and PEmax when compared with subjects with NMDs. PEmax/PImax ratio for healthy subjects was 1.31 ± 0.26, and PEmax%/PImax% was 1.04 ± 0.05; for subjects with NMDs, PEmax/PImax ratio was 1.45 ± 0.65, and PEmax%/PImax% ratio was 1.42 ± 0.67. We found that PEmax%/PImax% for myotonic dystrophy was 0.93 ± 0.24, for myasthenia gravis 1.94 ± 0.6, and for amyotrophic lateral sclerosis 1.33 ± 0.62 when we analyzed them separately. All healthy individuals showed higher PEmax compared with PImax. For subjects with NMDs, the impairment of PEmax and PImax is different among the 3 pathologies studied (P < .001). CONCLUSIONS: Healthy individuals and subjects with NMDs showed higher PEmax in comparison to PImax regarding the PEmax/PImax ratio. Based on the ratio, it is possible to state that NMDs show different patterns of respiratory muscle strength loss. PEmax/PImax ratio is a useful parameter to assess the impairment of respiratory muscles in a patient and to customize rehabilitation and treatment.
BACKGROUND:Neuromuscular diseases (NMDs) lead to different weakness patterns, and most patients with NMDs develop respiratory failure. Inspiratory and expiratory muscle strength can be measured by maximum static inspiratory pressure (PImax) and maximum static expiratory pressure (PEmax), and the relationship between them has not been well described in healthy subjects and subjects with NMDs. Our aim was to assess expiratory/inspiratory muscle strength in NMDs and healthy subjects and calculate PEmax/PImax ratio for these groups. METHODS: Seventy (35 males) subjects with NMDs (amyotrophic lateral sclerosis, myasthenia gravis, and myotonic dystrophy), and 93 (47 males) healthy individuals 20-80 y of age were evaluated for anthropometry, pulmonary function, PImax, and PEmax, respectively. RESULTS: Healthy individuals showed greater values for PImax and PEmax when compared with subjects with NMDs. PEmax/PImax ratio for healthy subjects was 1.31 ± 0.26, and PEmax%/PImax% was 1.04 ± 0.05; for subjects with NMDs, PEmax/PImax ratio was 1.45 ± 0.65, and PEmax%/PImax% ratio was 1.42 ± 0.67. We found that PEmax%/PImax% for myotonic dystrophy was 0.93 ± 0.24, for myasthenia gravis 1.94 ± 0.6, and for amyotrophic lateral sclerosis 1.33 ± 0.62 when we analyzed them separately. All healthy individuals showed higher PEmax compared with PImax. For subjects with NMDs, the impairment of PEmax and PImax is different among the 3 pathologies studied (P < .001). CONCLUSIONS: Healthy individuals and subjects with NMDs showed higher PEmax in comparison to PImax regarding the PEmax/PImax ratio. Based on the ratio, it is possible to state that NMDs show different patterns of respiratory muscle strength loss. PEmax/PImax ratio is a useful parameter to assess the impairment of respiratory muscles in a patient and to customize rehabilitation and treatment.
Authors: Morgana de Araújo Evangelista; Fernando Augusto Lavezzo Dias; Mário Emílio Teixeira Dourado Júnior; George Carlos do Nascimento; Antonio Sarmento; Lucien Peroni Gualdi; Andrea Aliverti; Vanessa Resqueti; Guilherme Augusto de Freitas Fregonezi Journal: PLoS One Date: 2017-06-08 Impact factor: 3.240
Authors: Abdallah Fayssoil; Lee S Nguyen; Adam Ogna; Tanya Stojkovic; Paris Meng; Dominique Mompoint; Robert Carlier; Helene Prigent; Bernard Clair; Anthony Behin; Pascal Laforet; Guillaume Bassez; Pascal Crenn; David Orlikowski; Djillali Annane; Bruno Eymard; Frederic Lofaso Journal: PLoS One Date: 2019-04-24 Impact factor: 3.240
Authors: Mi Ri Suh; Dong Hyun Kim; Jiho Jung; Bitnarae Kim; Jang Woo Lee; Won Ah Choi; Seong-Woong Kang Journal: Medicine (Baltimore) Date: 2019-05 Impact factor: 1.817
Authors: Maria Clara Rodrigues de Góes; Antonio Sarmento; Illia Lima; Marina Lyra; Cristiane Lima; Andrea Aliverti; Vanessa Resqueti; Guilherme A F Fregonezi Journal: PLoS One Date: 2022-10-14 Impact factor: 3.752